Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

Research output: Contribution to journalJournal articleResearchpeer-review

  • Melanie J. Davies
  • Vanita R. Aroda
  • Billy S. Collins
  • Robert A. Gabbay
  • Jennifer Green
  • Nisa M. Maruthur
  • Sylvia E. Rosas
  • Stefano Del Prato
  • Chantal Mathieu
  • Geltrude Mingrone
  • Rossing, Peter
  • Tsvetalina Tankova
  • Apostolos Tsapas
  • John B. Buse

The American Diabetes Association and the European Association for the Study of Diabetes convened a panel to update the previous consensus statements on the management of hyperglycemia in type 2 diabetes in adults, published since 2006 and last updated in 2019. The target audience is the full spectrum of the professional health care team providing diabetes care in the U.S. and Europe. A systematic examination of publications since 2018 informed new recommenda-tions. These include additional focus on social determinants of health, the health care system, and physical activity behaviors, including sleep. There is a greater emphasis on weight management as part of the holistic approach to diabetes management. The results of cardiovascular and kidney outcomes trials involving sodium–glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists, including assessment of subgroups, inform broader recommendations for cardiorenal protection in people with diabetes at high risk of cardiorenal dis-ease. After a summary listing of consensus recommendations, practical tips for implementation are provided.

Original languageEnglish
JournalDiabetes Care
Volume45
Issue number11
Pages (from-to)2753-2786
Number of pages34
ISSN0149-5992
DOIs
Publication statusPublished - 2022

Bibliographical note

Publisher Copyright:
© 2022 by the American Diabetes Association and the European Association for the Study of Diabetes.

ID: 334856269